HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma

Cancer Science
Qingzhu GaoNi Tang

Abstract

Hepatitis B virus X protein plays a crucial role in the pathogenesis of hepatocellular carcinoma. We previously showed that the tumor suppressor ARID2 inhibits hepatoma cell cycle progression and tumor growth. Here, we evaluated whether hepatitis B virus X protein was involved in the modulation of ARID2 expression and hepatocarcinogenesis associated with hepatitis B virus infection. ARID2 expression was downregulated in HBV-replicative hepatoma cells, HBV transgenic mice, and HBV-related clinical HCC tissues. The expression levels of HBx were negatively associated with those of ARID2 in hepatocellular carcinoma tissues. Furthermore, HBx suppressed ARID2 at transcriptional level. Mechanistically, the promoter region of ARID2 gene inhibited by HBx was located at nt-1040/nt-601 and contained potential ATOH1 binding elements. In addition, ectopic expression of ATOH1 or mutation of ATOH1 binding sites within ARID2 promoter partially abolished HBx-triggered ARID2 transcriptional repression. Functionally, ARID2 abrogated HBx-enhanced migration and proliferation of hepatoma cells, whereas depletion of ATOH1 enhanced tumorigenecity of HCC cells. Therefore, our findings suggested that deregulation of ARID2 by HBx through ATOH1 may be inv...Continue Reading

References

Mar 8, 2000·Microbiology and Molecular Biology Reviews : MMBR·C Seeger, W S Mason
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·J Helen LeonardRichard A Sturm
Apr 3, 2004·Molecular and Cellular Biology·Lisette MohrmannC Peter Verrijzer
Feb 7, 2006·The Journal of Laboratory and Clinical Medicine·Xiaodong ZhangLihong Ye
May 28, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xiaoying ZhangShuhan Sun
May 21, 2010·Pathologie-biologie·Y WeiM-A Buendia
Jan 14, 2011·Journal of Gastroenterology and Hepatology·Michael C Kew
Jun 8, 2011·Journal of Gastroenterology·Sue-Ann Ng, Caroline Lee
Jul 24, 2012·Cell·Eran HodisLynda Chin
Oct 11, 2012·International Journal of Cancer. Journal International Du Cancer·Gilles ManceauHélène Blons
May 2, 2013·Journal of Clinical Gastroenterology·Sahil Mittal, Hashem B El-Serag
Jan 1, 2014·International Journal of Cancer. Journal International Du Cancer·Qing XieNi Tang
Jan 3, 2014·International Journal of Cancer. Journal International Du Cancer·Tatiana CajusoPia Vahteristo
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
May 16, 2015·Journal of Experimental & Clinical Cancer Research : CR·Fei HeXiaoMin Wang
Jan 27, 2016·PloS One·Hidetsugu NakazatoToshikazu Ushijima
Apr 2, 2016·International Journal of Oncology·Li ZhangXuejun Sun
Jun 4, 2016·Journal of Experimental & Clinical Cancer Research : CR·Yu ZhangJinfeng Liu
Jun 29, 2016·World Journal of Gastroenterology : WJG·Hong KimBum-Joon Kim

❮ Previous
Next ❯

Methods Mentioned

BETA
protein assay
electrophoresis
Assay
fluorescence microscopy
immunoprecipitation
PCR
Ch

Software Mentioned

ImageJ
Image
Pro Plus

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.